Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-01 @ 12:13 PM
Study NCT ID:
NCT03977467
Status:
COMPLETED
Last Update Posted:
2025-08-27
First Post:
2019-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-09
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-30
First Submit QC Date:
None
Study First Post Date:
2019-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-08
Results First Submit QC Date:
None
Results First Post Date:
2025-08-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-08
Last Update Post Date:
2025-08-27
Last Update Post Date Type:
ESTIMATED